Literature DB >> 12937269

Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.

Thorsten Sadowski1, Sebastian Dietrich, Felix Koschinsky, Radislav Sedlacek.   

Abstract

Unlike most other matrix metalloproteinases (MMPs) MMP-19 is expressed in undifferentiated basal keratinocytes of healthy human skin. The human keratinocyte cell line HaCaT, which like basal keratinocytes constitutively expresses MMP-19, down-regulated the expression of MMP-19 at high calcium concentrations. Calcium-regulation occurred through E-cadherin mediated cell-cell contacts because neutralizing anti-E-cadherin antibodies restored MMP-19 expression in high calcium. Overexpression of MMP-19 in HaCaT cells (HaCaT-WT) increased cellular proliferation, as well as migration and adhesion on type I collagen. This was due to proteolysis of the insulin-like growth factor (IGF) binding protein-3 by MMP-19, which augmented signaling through the IGF-I receptor, as evidenced by its increased autophosphorylation. Conversely, these effects were not observed in cells transfected with MMP-2 or a catalytically inactive MMP-19 mutant. As further proof that increased IGF-signaling promoted adhesion and migration in HaCaT-WT cells, we reproduced these effects by treating parental HaCaT with IGF-I. We observed dephosphorylation of the focal adhesion kinase in HaCaT-WT as well as IGF-I-treated HaCaT cells, suggesting that inactivating focal adhesion kinase is a mechanism by which IGF-I enhances adhesion. Furthermore, IGF-I-triggered motility on type I collagen was mediated by MMP activity, which, however, was distinct from MMP-19. Considering the coexpression of IGFBP-3 and MMP-19 in the skin, we conclude that MMP-19 is a likely candidate to be the major IGFBP-3 degrading MMP in the quiescent epidermis. This activity might have widespread consequences for the behavior of epidermal keratinocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12937269      PMCID: PMC266773          DOI: 10.1091/mbc.e03-01-0009

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  60 in total

1.  Functional overlap between two classes of matrix-degrading proteases in wound healing.

Authors:  L R Lund; J Romer; T H Bugge; B S Nielsen; T L Frandsen; J L Degen; R W Stephens; K Danø
Journal:  EMBO J       Date:  1999-09-01       Impact factor: 11.598

2.  Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.

Authors:  E Morgunova; A Tuuttila; U Bergmann; M Isupov; Y Lindqvist; G Schneider; K Tryggvason
Journal:  Science       Date:  1999-06-04       Impact factor: 47.728

Review 3.  Matrix metalloproteinases: a review.

Authors:  H Birkedal-Hansen; W G Moore; M K Bodden; L J Windsor; B Birkedal-Hansen; A DeCarlo; J A Engler
Journal:  Crit Rev Oral Biol Med       Date:  1993

Review 4.  Vitamin D, calcium, and epidermal differentiation.

Authors:  D D Bikle; S Pillai
Journal:  Endocr Rev       Date:  1993-02       Impact factor: 19.871

5.  The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Authors:  H C Crawford; B M Fingleton; L A Rudolph-Owen; K J Goss; B Rubinfeld; P Polakis; L M Matrisian
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

6.  Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth.

Authors:  N Buisson-Legendre; P Bernard; H Bobichon; H Emonard; C Schneider; F X Maquart; B Haye; W Hornebeck
Journal:  Biochem Biophys Res Commun       Date:  1999-07-14       Impact factor: 3.575

7.  Signal transduction by beta1 integrin receptors in human chondrocytes in vitro: collaboration with the insulin-like growth factor-I receptor.

Authors:  M Shakibaei; T John; P De Souza; R Rahmanzadeh; H J Merker
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

Review 8.  Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity.

Authors:  B K Pilcher; M Wang; X J Qin; W C Parks; R M Senior; H G Welgus
Journal:  Ann N Y Acad Sci       Date:  1999-06-30       Impact factor: 5.691

9.  beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer.

Authors:  T Brabletz; A Jung; S Dag; F Hlubek; T Kirchner
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

10.  Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin.

Authors:  A Tavakkol; J T Elder; C E Griffiths; K D Cooper; H Talwar; G J Fisher; K M Keane; S K Foltin; J J Voorhees
Journal:  J Invest Dermatol       Date:  1992-09       Impact factor: 8.551

View more
  32 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

Review 3.  The Roles of Growth Factors in Keratinocyte Migration.

Authors:  Mark A Seeger; Amy S Paller
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-04-01       Impact factor: 4.730

4.  Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional events.

Authors:  Jai-Hyun Kim; Dong Soon Choi; Ok-Hee Lee; Seung-Hyun Oh; Scott M Lippman; Ho-Young Lee
Journal:  Blood       Date:  2011-05-06       Impact factor: 22.113

5.  [Expression of matrix metalloproteinase-19 in the human cornea. Wound healing in the MMP-19 knock-out mouse model].

Authors:  F Treumer; C Flöhr; A Klettner; B Nölle; J Roider
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

6.  Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics.

Authors:  Anna Prudova; Ulrich auf dem Keller; Georgina S Butler; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2010-03-20       Impact factor: 5.911

7.  Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer.

Authors:  P Massoner; M Ladurner-Rennau; I E Eder; H Klocker
Journal:  Br J Cancer       Date:  2010-10-05       Impact factor: 7.640

8.  Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice.

Authors:  Peter H Larsen; Angelika Goncalves DaSilva; Katherine Conant; V Wee Yong
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

9.  Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration.

Authors:  Salma Taboubi; Françoise Garrouste; Fabrice Parat; Gilbert Pommier; Emilie Faure; Sylvie Monferran; Hervé Kovacic; Maxime Lehmann
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

10.  MMPs regulate both development and immunity in the tribolium model insect.

Authors:  Eileen Knorr; Henrike Schmidtberg; Andreas Vilcinskas; Boran Altincicek
Journal:  PLoS One       Date:  2009-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.